Bio Plus Co., Ltd (099430.KQ)
KRW 7530.0
(0.53%)
KRW 7530.0
(0.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 16.04 Billion | 13.35 Billion | 13.35 Billion | 10.04 Billion | 4.96 Billion |
| Net Income | 27.42 Billion | 20.7 Billion | 10.67 Billion | 9.7 Billion | 5.62 Billion |
| Depreciation & Amortization | 2.49 Billion | 1.88 Billion | 1.29 Billion | 1.01 Billion | 866.81 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 188.38 Million | 449.99 Million | 35.98 Million | 151.38 Million | 114.98 Million |
| Change in working capital | -6.3 Billion | -12.45 Billion | -4.04 Billion | -2.83 Billion | -3.38 Billion |
| Other non-cash items | -3.35 Billion | -106.22 Million | 362.08 Million | 39.98 Million | 1.74 Billion |
| Investing Cash Flow | 21.72 Billion | -67.13 Billion | -22.63 Billion | -1.57 Billion | -5.41 Billion |
| Investments in PPE | -21.57 Billion | -6.69 Billion | -15.35 Billion | -1.09 Billion | -5.91 Billion |
| Acquisitions | 2.1 Billion | 2.7 Billion | -2.69 Billion | - | - |
| Investment purchases | -216.01 Billion | -63.06 Billion | -2.99 Billion | -499.99 Million | - |
| Sales/Maturities of investments | 257.19 Billion | - | - | - | 1.04 Billion |
| Other Investing Activities | -67.82 Million | -121.15 Million | -212.23 Million | 15.08 Million | 499.71 Million |
| Financing Cash Flow | -10.21 Billion | 30.65 Billion | 34.04 Billion | 4.82 Billion | -126.32 Million |
| Debt repayment | -1.04 Billion | -612.77 Million | -274.37 Million | -5 Billion | -120.97 Million |
| Dividends payments | -4.24 Billion | - | - | - | - |
| Common Stock Repurchased | -4.99 Billion | -1.18 Billion | -8.79 Billion | - | - |
| Common Stock Issuance | 300 Million | 12.47 Billion | 45.49 Billion | - | - |
| Other Financing Activities | -3.76 Billion | -15 Million | -2.09 Billion | - | -5.34 Million |
| Accounts receivables | -5.25 Billion | -8.67 Billion | -3.62 Billion | -1.79 Billion | -2.88 Billion |
| Accounts payables | - | - | - | - | - |
| Inventory | 2.33 Billion | -4.15 Billion | -66.01 Million | -933.12 Million | -1.34 Billion |
| Other working capital | -2.4 Billion | 213.89 Million | -569.51 Million | -512.37 Million | 837.75 Million |
| Cash at beginning of period | 18.35 Billion | 41.02 Billion | 15.99 Billion | 2.84 Billion | 3.43 Billion |
| Cash at end of period | 46 Billion | 18.35 Billion | 41.02 Billion | 15.99 Billion | 2.84 Billion |
| Capital Expenditure | -21.57 Billion | -6.69 Billion | -15.35 Billion | -1.09 Billion | -5.91 Billion |
| Effect of forex changes on cash | 95.82 Million | 434.57 Million | 271.95 Million | -146.91 Million | -12.79 Million |
| Net cash flow / Change in cash | 27.65 Billion | -22.67 Billion | 25.03 Billion | 13.14 Billion | -588.87 Million |
| Free Cash Flow | -5.53 Billion | 6.66 Billion | -2 Billion | 8.94 Billion | -949.48 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.57 Billion | 2.65 Billion | 27.42 Billion | 7.08 Billion | 6.6 Billion | 7.76 Billion |
| Depreciation & Amortization | 810.89 Million | 737.45 Million | 2.49 Billion | 642.09 Million | 685.59 Million | 619.8 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 4.63 Million | 61.74 Million | 188.38 Million | 92.45 Million | 27.74 Million | -6.61 Million |
| Change in working capital | 1.09 Billion | 9.91 Billion | -6.3 Billion | -949.01 Million | 1.02 Billion | -7.12 Billion |
| Other non-cash items | -4.95 Billion | -477.65 Million | -3.35 Billion | -499.5 Million | -617.18 Million | -1.55 Billion |
| Investing Cash Flow | -24.44 Billion | -7.78 Billion | 21.72 Billion | 32.05 Billion | -4.37 Billion | 4.48 Billion |
| Investments in PPE | -25.03 Billion | -19.95 Billion | -21.57 Billion | -10.09 Billion | -2.42 Billion | -7.62 Billion |
| Acquisitions | - | - | 2.1 Billion | -199.42 Million | - | - |
| Investment purchases | - | -1.9 Billion | -216.01 Billion | -10.78 Billion | -81.12 Billion | -115.1 Billion |
| Sales/Maturities of investments | - | 14 Billion | 257.19 Billion | 52.1 Billion | 80.1 Billion | - |
| Other Investing Activities | 582.75 Million | -14.85 Million | -67.82 Million | 18.45 Million | -31.34 Million | -1.21 Million |
| Financing Cash Flow | -6.05 Billion | 2.42 Billion | -10.21 Billion | -1.09 Billion | -3.34 Billion | -5.72 Billion |
| Debt repayment | -210.58 Million | -2.62 Billion | -1.04 Billion | -543.53 Million | -43.53 Million | - |
| Dividends payments | -4.19 Billion | - | -4.24 Billion | - | - | -4.24 Billion |
| Common Stock Repurchased | -1.36 Billion | - | -4.99 Billion | - | -123.4 Million | -4.99 Billion |
| Common Stock Issuance | - | - | 300 Million | - | - | - |
| Other Financing Activities | -283.91 Million | 2.62 Billion | -3.76 Billion | -703.6 Million | -3.06 Billion | -124.6 Million |
| Accounts receivables | 4.48 Billion | 6.96 Billion | -5.25 Billion | -1.45 Billion | -1.59 Billion | -2.54 Billion |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 1.09 Billion | -266.43 Million | 2.33 Billion | 151.58 Million | 270.74 Million | 1.62 Billion |
| Other working capital | -4.49 Billion | 3.41 Billion | -2.4 Billion | 1.12 Billion | 2.14 Billion | -5.49 Billion |
| Cash at beginning of period | 53.21 Billion | 46 Billion | 18.35 Billion | 7.78 Billion | 8.06 Billion | 13.29 Billion |
| Cash at end of period | 25.51 Billion | 53.21 Billion | 46 Billion | 46 Billion | 7.78 Billion | 8.06 Billion |
| Capital Expenditure | -25.03 Billion | -19.95 Billion | -21.57 Billion | -10.09 Billion | -2.42 Billion | -7.62 Billion |
| Effect of forex changes on cash | 280.15 Million | 230.81 Million | 95.82 Million | -105.46 Million | -16.04 Million | -20.84 Million |
| Net cash flow / Change in cash | -27.69 Billion | 7.2 Billion | 27.65 Billion | 38.21 Billion | -274.74 Million | -5.22 Billion |
| Free Cash Flow | -22.5 Billion | -7.62 Billion | -5.53 Billion | -2.72 Billion | 5.04 Billion | -11.59 Billion |
9072
OM
ZPHYF
BNAIW
EBRGF
AHR